GALILEO CONSULTING GROUP, INC. for AMERICAN UROGYNECOLOGIC SOCIETY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6363, Further Continuing Appropriations and Other Extensions Act, 2024, which provides fiscal year 2024 appropriations to Federal agencies through January 19, 2024, Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), Report Language Submissions regarding Precision Medicine and Urinary Incontinence and research connected to pregnancy and pelvic organ prolapse. - House and Senate Appropriations Committees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Medicare/Medicaid MMM
H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024, which provides fiscal year 2024 appropriations to Federal agencies through January 19, 2024; H.R. 2474, the Strengthening Medicare for Patients and Providers Act. - Meetings regarding Medicare physician payment for 2024 and beyond.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL RATHBUN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.